7ZB7
| Crystal Structure of SARS-CoV-2 Main Protease (Mpro) variant Y54F at 1.63 A resolution | 分子名称: | 3C-like proteinase nsp5, DIMETHYL SULFOXIDE, GLYCEROL | 著者 | Paknia, E, Rabe von Pappenheim, F, Funk, L.-M, Tittmann, K, Chari, A. | 登録日 | 2022-03-23 | 公開日 | 2022-06-01 | 最終更新日 | 2024-01-31 | 実験手法 | X-RAY DIFFRACTION (1.63 Å) | 主引用文献 | Multiple redox switches of the SARS-CoV-2 main protease in vitro provide opportunities for drug design. Nat Commun, 15, 2024
|
|
7ZB8
| Crystal Structure of SARS-CoV-2 Main Protease (Mpro) variant K61A at 2.48 A resolution | 分子名称: | 3C-like proteinase nsp5, DIMETHYL SULFOXIDE | 著者 | Paknia, E, Rabe von Pappenheim, F, Funk, L.-M, Tittmann, K, Chari, A. | 登録日 | 2022-03-23 | 公開日 | 2022-06-01 | 最終更新日 | 2024-01-31 | 実験手法 | X-RAY DIFFRACTION (2.48 Å) | 主引用文献 | Multiple redox switches of the SARS-CoV-2 main protease in vitro provide opportunities for drug design. Nat Commun, 15, 2024
|
|
7ZF3
| SARS-CoV-2 Omicron RBD in complex with Omi-3 and EY6A Fabs | 分子名称: | EY6A heavy chain, EY6A light chain, GLYCEROL, ... | 著者 | Zhou, D, Huo, J, Ren, J, Stuart, D.I. | 登録日 | 2022-04-01 | 公開日 | 2022-06-01 | 最終更新日 | 2024-01-31 | 実験手法 | X-RAY DIFFRACTION (3.15 Å) | 主引用文献 | Potent cross-reactive antibodies following Omicron breakthrough in vaccinees. Cell, 185, 2022
|
|
7ZF5
| SARS-CoV-2 Omicron RBD in complex with Omi-12 and Beta-54 Fabs | 分子名称: | Beta-54 heavy chain, Beta-54 light chain, Omi-12 heavy chain, ... | 著者 | Zhou, D, Huo, J, Ren, J, Stuart, D.I. | 登録日 | 2022-04-01 | 公開日 | 2022-06-01 | 最終更新日 | 2024-01-31 | 実験手法 | X-RAY DIFFRACTION (5.32 Å) | 主引用文献 | Potent cross-reactive antibodies following Omicron breakthrough in vaccinees. Cell, 185, 2022
|
|
7ZF7
| SARS-CoV-2 Omicron BA.2 RBD in complex with ACE2 | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, Processed angiotensin-converting enzyme 2, Spike protein S1, ... | 著者 | Zhou, D, Huo, J, Ren, J, Stuart, D.I. | 登録日 | 2022-04-01 | 公開日 | 2022-06-01 | 最終更新日 | 2024-01-31 | 実験手法 | X-RAY DIFFRACTION (3.46 Å) | 主引用文献 | Potent cross-reactive antibodies following Omicron breakthrough in vaccinees. Cell, 185, 2022
|
|
7ZF8
| SARS-CoV-2 Omicron BA.2 RBD in complex with COVOX-150 Fab | 分子名称: | COVOX-150 heavy chain, COVOX-150 light chain, Spike protein S1 | 著者 | Zhou, D, Huo, J, Ren, J, Stuart, D.I. | 登録日 | 2022-04-01 | 公開日 | 2022-06-01 | 最終更新日 | 2024-10-16 | 実験手法 | X-RAY DIFFRACTION (2.95 Å) | 主引用文献 | Potent cross-reactive antibodies following Omicron breakthrough in vaccinees. Cell, 185, 2022
|
|
7ZFB
| SARS-CoV-2 Omicron RBD in complex with nanobody C1, Omi-18 and Omi-31 Fabs | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, Nanobody C1, Omi-18 heavy chain, ... | 著者 | Zhou, D, Huo, J, Ren, J, Stuart, D.I. | 登録日 | 2022-04-01 | 公開日 | 2022-06-01 | 最終更新日 | 2024-01-31 | 実験手法 | X-RAY DIFFRACTION (3.08 Å) | 主引用文献 | Potent cross-reactive antibodies following Omicron breakthrough in vaccinees. Cell, 185, 2022
|
|
7ZFC
| SARS-CoV-2 Beta RBD in complex with nanobody C1, Omi-18 and Omi-31 Fabs | 分子名称: | Nanobody C1, Omi-18 heavy chain, Omi-18 light chain, ... | 著者 | Zhou, D, Huo, J, Ren, J, Stuart, D.I. | 登録日 | 2022-04-01 | 公開日 | 2022-06-01 | 最終更新日 | 2024-01-31 | 実験手法 | X-RAY DIFFRACTION (3.24 Å) | 主引用文献 | Potent cross-reactive antibodies following Omicron breakthrough in vaccinees. Cell, 185, 2022
|
|
7ZFD
| SARS-CoV-2 Omicron RBD in complex with Omi-25 Fab | 分子名称: | Omi-25 heavy chain, Omi-25 light chain, Spike protein S1 | 著者 | Zhou, D, Huo, J, Ren, J, Stuart, D.I. | 登録日 | 2022-04-01 | 公開日 | 2022-06-01 | 最終更新日 | 2024-10-16 | 実験手法 | X-RAY DIFFRACTION (3.39 Å) | 主引用文献 | Potent cross-reactive antibodies following Omicron breakthrough in vaccinees. Cell, 185, 2022
|
|
7ZFE
| SARS-CoV-2 Omicron RBD in complex with Omi-32 Fab and nanobody C1 | 分子名称: | Nanobody C1, Omi-32 heavy chain, Omi-32 light chain, ... | 著者 | Zhou, D, Huo, J, Ren, J, Stuart, D.I. | 登録日 | 2022-04-01 | 公開日 | 2022-06-01 | 最終更新日 | 2024-01-31 | 実験手法 | X-RAY DIFFRACTION (3.25 Å) | 主引用文献 | Potent cross-reactive antibodies following Omicron breakthrough in vaccinees. Cell, 185, 2022
|
|
7ZR7
| OMI-42 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Omi-42 heavy chain, ... | 著者 | Duyvesteyn, H.M.E, Ren, J, Stuart, D.I. | 登録日 | 2022-05-03 | 公開日 | 2022-06-01 | 最終更新日 | 2024-10-16 | 実験手法 | ELECTRON MICROSCOPY (3.7 Å) | 主引用文献 | Potent cross-reactive antibodies following Omicron breakthrough in vaccinees. Cell, 185, 2022
|
|
7ZR9
| OMI-2 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Omi-2 Fab heavy chain, ... | 著者 | Duyvesteyn, H.M.E, Ren, J, Stuart, D.I. | 登録日 | 2022-05-03 | 公開日 | 2022-06-01 | 最終更新日 | 2022-06-22 | 実験手法 | ELECTRON MICROSCOPY (4 Å) | 主引用文献 | Potent cross-reactive antibodies following Omicron breakthrough in vaccinees. Cell, 185, 2022
|
|
7ZRC
| OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Omi-38 Fab Heavy Chain, ... | 著者 | Duyvesteyn, H.M.E, Ren, J, Stuart, D.I. | 登録日 | 2022-05-04 | 公開日 | 2022-06-01 | 最終更新日 | 2022-06-22 | 実験手法 | ELECTRON MICROSCOPY (3.5 Å) | 主引用文献 | Potent cross-reactive antibodies following Omicron breakthrough in vaccinees. Cell, 185, 2022
|
|
7R4I
| The SARS-CoV-2 spike in complex with the 2.15 neutralizing nanobody | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Camel-derived nanobody 2.15, ... | 著者 | Casasnovas, J.M, Melero, R, Arranz, R, Fernandez, L.A. | 登録日 | 2022-02-08 | 公開日 | 2022-06-08 | 実験手法 | ELECTRON MICROSCOPY (3.2 Å) | 主引用文献 | Nanobodies Protecting From Lethal SARS-CoV-2 Infection Target Receptor Binding Epitopes Preserved in Virus Variants Other Than Omicron. Front Immunol, 13, 2022
|
|
7R4Q
| The SARS-CoV-2 spike in complex with the 1.29 neutralizing nanobody | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Camel-derived nanobody 1.29, ... | 著者 | Casasnovas, J.M, Melero, R, Arranz, R, Fernandez, L.A. | 登録日 | 2022-02-09 | 公開日 | 2022-06-08 | 実験手法 | ELECTRON MICROSCOPY (3.6 Å) | 主引用文献 | Nanobodies Protecting From Lethal SARS-CoV-2 Infection Target Receptor Binding Epitopes Preserved in Virus Variants Other Than Omicron. Front Immunol, 13, 2022
|
|
7R4R
| The SARS-CoV-2 spike in complex with the 1.10 neutralizing nanobody | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Camel-derived nanobody 1.10, ... | 著者 | Casasnovas, J.M, Melero, R, Arranz, R, Fernandez, L.A. | 登録日 | 2022-02-09 | 公開日 | 2022-06-08 | 実験手法 | ELECTRON MICROSCOPY (3.9 Å) | 主引用文献 | Nanobodies Protecting From Lethal SARS-CoV-2 Infection Target Receptor Binding Epitopes Preserved in Virus Variants Other Than Omicron. Front Immunol, 13, 2022
|
|
7SD4
| SARS-CoV-2 Nucleocapsid N-terminal domain (N-NTD) protein | 分子名称: | Nucleoprotein | 著者 | Sarkar, S, Runge, B, Russell, R.W, Calero, D, Zeinalilathori, S, Quinn, C.M, Lu, M, Calero, G, Gronenborn, A.M, Polenova, T. | 登録日 | 2021-09-29 | 公開日 | 2022-06-08 | 最終更新日 | 2024-05-15 | 実験手法 | SOLID-STATE NMR | 主引用文献 | Atomic-Resolution Structure of SARS-CoV-2 Nucleocapsid Protein N-Terminal Domain. J.Am.Chem.Soc., 144, 2022
|
|
7UHC
| |
7W6U
| Structure of SARS-CoV-2 spike receptor-binding domain complexed with its receptor equine ACE2 | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, Angiotensin-converting enzyme, Spike protein S1, ... | 著者 | Xu, Z.P, Liu, K.F, Han, P, Qi, J.X. | 登録日 | 2021-12-02 | 公開日 | 2022-06-08 | 最終更新日 | 2024-10-16 | 実験手法 | X-RAY DIFFRACTION (2.56 Å) | 主引用文献 | Binding and structural basis of equine ACE2 to RBDs from SARS-CoV, SARS-CoV-2 and related coronaviruses Nat Commun, 13, 2022
|
|
7WRI
| Cryo-EM structure of SARS-CoV-2 Omicron spike receptor-binding domain in complex with mouse ACE2 | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, Processed angiotensin-converting enzyme 2, Spike glycoprotein, ... | 著者 | Han, P, Xie, Y, Qi, J. | 登録日 | 2022-01-26 | 公開日 | 2022-06-08 | 最終更新日 | 2022-12-21 | 実験手法 | ELECTRON MICROSCOPY (3.03 Å) | 主引用文献 | Broader-species receptor binding and structural bases of Omicron SARS-CoV-2 to both mouse and palm-civet ACE2s. Cell Discov, 8, 2022
|
|
7WSK
| Crystal structure of SARS-CoV-2 Omicron spike receptor-binding domain in complex with civet ACE2 | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, Processed angiotensin-converting enzyme 2, Spike protein S1, ... | 著者 | Huang, B, Han, P, Qi, J. | 登録日 | 2022-01-29 | 公開日 | 2022-06-08 | 最終更新日 | 2023-11-29 | 実験手法 | X-RAY DIFFRACTION (3.3 Å) | 主引用文献 | Broader-species receptor binding and structural bases of Omicron SARS-CoV-2 to both mouse and palm-civet ACE2s. Cell Discov, 8, 2022
|
|
7XBY
| The crystal structure of SARS-CoV-2 Omicron BA.1 variant RBD in complex with equine ACE2 | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, Angiotensin-converting enzyme, BROMIDE ION, ... | 著者 | Xu, Z.P, Liu, K.F, Han, P, Qi, J.X. | 登録日 | 2022-03-22 | 公開日 | 2022-06-08 | 最終更新日 | 2023-11-29 | 実験手法 | X-RAY DIFFRACTION (2.85 Å) | 主引用文献 | Binding and structural basis of equine ACE2 to RBDs from SARS-CoV, SARS-CoV-2 and related coronaviruses. Nat Commun, 13, 2022
|
|
7ZF4
| SARS-CoV-2 Omicron RBD in complex with Omi-9 Fab and nanobody F2 | 分子名称: | Nanobody F2, Omi-9 heavy chain, Omi-9 light chain, ... | 著者 | Zhou, D, Huo, J, Ren, J, Stuart, D.I. | 登録日 | 2022-04-01 | 公開日 | 2022-06-08 | 最終更新日 | 2024-01-31 | 実験手法 | X-RAY DIFFRACTION (4.18 Å) | 主引用文献 | Potent cross-reactive antibodies following Omicron breakthrough in vaccinees. Cell, 185, 2022
|
|
7F0X
| A SARS-CoV-2 neutralizing antibody | 分子名称: | Antibody, Spike protein S1 | 著者 | Zhang, G, Li, X, Guo, Y, Wang, Y, Yuan, S. | 登録日 | 2021-06-07 | 公開日 | 2022-06-15 | 最終更新日 | 2023-11-29 | 実験手法 | X-RAY DIFFRACTION (2.8 Å) | 主引用文献 | A SARS-CoV-2 neutralizing
antibody To Be Published
|
|
7F12
| A SARS-CoV-2 neutralizing antibody | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, Antibody, Spike protein S1 | 著者 | Zhang, G, Li, X, Guo, Y, Wang, Y, Yuan, S. | 登録日 | 2021-06-07 | 公開日 | 2022-06-15 | 最終更新日 | 2023-11-29 | 実験手法 | X-RAY DIFFRACTION (3.15 Å) | 主引用文献 | A SARS-CoV-2 neutralizing
antibody To Be Published
|
|